FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2618652138> ?p ?o ?g. }

• W2618652138 endingPage "772" @default.
• W2618652138 startingPage "764" @default.
• W2618652138 abstract "Previous studies demonstrated that herpes simplex virus thymidine kinase (HSVtk) could phosphorylate non‑toxic gancyclovir (GCV) efficiently to produce phosphorylated products that result in cell apoptosis, to kill tumor cells. The present study aimed to construct a plasmid vector, pcDNA3.1‑pAFP‑TK, carrying the suicide gene driven by the alpha‑fetoprotein (AFP) promoter, to investigate the cytotoxicity of HSVtk/GCV suicide gene system on hepatoma carcinoma cells. Reverse transcription‑polymerase chain reaction and western blotting results demonstrated that the HSVtk gene was effectively expressed in HepG2 hepatoma carcinoma cells transfected with pcDNA3.1‑pAFP‑TK plasmid, whereas HSVtk gene expression was not detected in normal HL‑7702 liver cells. In addition, MTT assays indicated that cell viability of HepG2 cells with the plasmid pcDNA3.1‑pAFP‑TK decreased in a dose‑dependent manner following treatment with GCV for 48 h. Flow cytometry also revealed that the cell apoptosis rate and mitochondrial membrane potential reduction rate in the HepG2 cells treated with HSVtk/GCV suicide gene system were significantly higher than in the control group. Apoptosis rates in the control group and the pcDNA3.1‑pAFP‑TK group were (1.00±0.62%) and (38.70±6.03%), respectively. Mitochondrial membrane potential reduction rates in the control group and the pcDNA3.1-pAFP-TK group were (0.57±0.11%) and (22.84±5.79%), respectively. Caspase‑3 staining demonstrated that activated caspase‑3 increased significantly in the HepG2 cells treated with HSVtk/GCV suicide gene system, whereas in the control group activated caspase‑3 increase was not observed. The results of the present study, therefore, indicated that HSVtk suicide gene was obviously expressed in the HepG2 cells and that the HSVtk/GCV system was effective at killing HepG2 hepatoma carcinoma cells." @default.
• W2618652138 created "2017-06-05" @default.
• W2618652138 creator A5008131726 @default.
• W2618652138 creator A5008857498 @default.
• W2618652138 creator A5010576623 @default.
• W2618652138 creator A5015753176 @default.
• W2618652138 creator A5023858361 @default.
• W2618652138 creator A5037743510 @default.
• W2618652138 creator A5037993198 @default.
• W2618652138 creator A5039334635 @default.
• W2618652138 creator A5045864062 @default.
• W2618652138 creator A5048631551 @default.
• W2618652138 creator A5058484759 @default.
• W2618652138 creator A5062796567 @default.
• W2618652138 creator A5063666024 @default.
• W2618652138 creator A5077069400 @default.
• W2618652138 date "2017-01-01" @default.
• W2618652138 modified "2023-09-27" @default.
• W2618652138 title "HSVtk/GCV system on hepatoma carcinoma cells: Construction of the plasmid pcDNA3.1-pAFP-TK and targeted killing effect" @default.
• W2618652138 cites W1486451451 @default.
• W2618652138 cites W1539522283 @default.
• W2618652138 cites W1589238463 @default.
• W2618652138 cites W1598512923 @default.
• W2618652138 cites W1638355081 @default.
• W2618652138 cites W1966636348 @default.
• W2618652138 cites W1967657062 @default.
• W2618652138 cites W1967695773 @default.
• W2618652138 cites W1971837077 @default.
• W2618652138 cites W1972728563 @default.
• W2618652138 cites W1982315589 @default.
• W2618652138 cites W1987486134 @default.
• W2618652138 cites W1993965529 @default.
• W2618652138 cites W1994193851 @default.
• W2618652138 cites W2009799605 @default.
• W2618652138 cites W2017593380 @default.
• W2618652138 cites W2036663141 @default.
• W2618652138 cites W2077633268 @default.
• W2618652138 cites W2079755093 @default.
• W2618652138 cites W2088629624 @default.
• W2618652138 cites W2103637700 @default.
• W2618652138 cites W2121600817 @default.
• W2618652138 cites W2126928946 @default.
• W2618652138 cites W2127447177 @default.
• W2618652138 cites W2135309651 @default.
• W2618652138 cites W2144715892 @default.
• W2618652138 cites W2153935627 @default.
• W2618652138 cites W2326214229 @default.
• W2618652138 cites W2533275386 @default.
• W2618652138 cites W4302594494 @default.
• W2618652138 doi "https://doi.org/10.3892/mmr.2017.6657" @default.
• W2618652138 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5482189" @default.
• W2618652138 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28560395" @default.
• W2618652138 hasPublicationYear "2017" @default.
• W2618652138 type Work @default.
• W2618652138 sameAs 2618652138 @default.
• W2618652138 citedByCount "9" @default.
• W2618652138 countsByYear W26186521382019 @default.
• W2618652138 countsByYear W26186521382020 @default.
• W2618652138 countsByYear W26186521382021 @default.
• W2618652138 countsByYear W26186521382022 @default.
• W2618652138 crossrefType "journal-article" @default.
• W2618652138 hasAuthorship W2618652138A5008131726 @default.
• W2618652138 hasAuthorship W2618652138A5008857498 @default.
• W2618652138 hasAuthorship W2618652138A5010576623 @default.
• W2618652138 hasAuthorship W2618652138A5015753176 @default.
• W2618652138 hasAuthorship W2618652138A5023858361 @default.
• W2618652138 hasAuthorship W2618652138A5037743510 @default.
• W2618652138 hasAuthorship W2618652138A5037993198 @default.
• W2618652138 hasAuthorship W2618652138A5039334635 @default.
• W2618652138 hasAuthorship W2618652138A5045864062 @default.
• W2618652138 hasAuthorship W2618652138A5048631551 @default.
• W2618652138 hasAuthorship W2618652138A5058484759 @default.
• W2618652138 hasAuthorship W2618652138A5062796567 @default.
• W2618652138 hasAuthorship W2618652138A5063666024 @default.
• W2618652138 hasAuthorship W2618652138A5077069400 @default.
• W2618652138 hasBestOaLocation W26186521381 @default.
• W2618652138 hasConcept C104317684 @default.
• W2618652138 hasConcept C111599444 @default.
• W2618652138 hasConcept C153911025 @default.
• W2618652138 hasConcept C159047783 @default.
• W2618652138 hasConcept C185592680 @default.
• W2618652138 hasConcept C190283241 @default.
• W2618652138 hasConcept C2522874641 @default.
• W2618652138 hasConcept C2776147627 @default.
• W2618652138 hasConcept C2781196997 @default.
• W2618652138 hasConcept C34981463 @default.
• W2618652138 hasConcept C502942594 @default.
• W2618652138 hasConcept C54009773 @default.
• W2618652138 hasConcept C54355233 @default.
• W2618652138 hasConcept C55493867 @default.
• W2618652138 hasConcept C81885089 @default.
• W2618652138 hasConcept C86803240 @default.
• W2618652138 hasConceptScore W2618652138C104317684 @default.
• W2618652138 hasConceptScore W2618652138C111599444 @default.
• W2618652138 hasConceptScore W2618652138C153911025 @default.
• W2618652138 hasConceptScore W2618652138C159047783 @default.
• W2618652138 hasConceptScore W2618652138C185592680 @default.
• W2618652138 hasConceptScore W2618652138C190283241 @default.

• next